Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MDL 105519

Known as: MDL 105,519, MDL-105519 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
RationaleMany N-methyl-d-aspartate (NMDA) antagonists produce phencyclidine (PCP)-like side effects that limit their clinical… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
In an investigation of the mechanisms of the neuroprotective effects of theanine (gamma-glutamylethylamide) in brain ischemia… Expand
  • table 1
Is this relevant?
2001
2001
The use of trifluoroperazine in a well washed rat brain membrane preparation revealed [(3)H]ifenprodil binding to a single high… Expand
Is this relevant?
1997
1997
MDL 105,519, (E)-3-(2-phenyl-2-carboxyethenyl)-4,6-dichloro-1 H-indole-2-carboxylic acid, is a potent and selective inhibitor of… Expand
Is this relevant?